Protalix Biotherapeutics, Inc.(NYSE Amex Equities : PLX)
PLX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Services » Servicestothe Health Industry
|DGX||Quest Diagnostics, Inc.||1.45%||145.80||4.7%||$194.39m|
|IQV||IQVIA Holdings, Inc.||0.22%||249.01||0.0%||$167.53m|
|LH||Laboratory Corp. of America Holdings||0.65%||276.06||2.4%||$149.44m|
|AMEH||Apollo Medical Holdings, Inc.||-3.68%||69.38||0.0%||$40.84m|
|PLX||Protalix Biotherapeutics, Inc.||1.23%||1.24||18.5%||$1.20m|
|NRC||National Research Corp.||1.76%||43.41||0.0%||$0.85m|
|QIPT||Quipt Home Medical Corp.||-2.39%||5.72||0.0%||$0.29m|
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.